The online conversations about breast cancer drug Kadcyla before it was approved by NICE.
FDA panel backs Herceptin and Avastin biosimilars.
Emerging technologies in Microbiome discovery
Watson for Genomics produces treatment insights for glioblastoma in 10 minutes.
Report raises concerns about outcome of MYSTIC trial.
Panel unanimously back CTL019
EU inspectors require re-inspection of Bangalore plant.
Mylotarg backed by advisers after withdrawal in 2010.